GSK plc reports

Company location
London
GSK plc has filed 6,789 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
SD File 001-15170

SPECIALIZED DISCLOSURE

Filing date
27 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK CERVARIX TWO-DOSE SCHEDULE APPROVED BY NMPA

Filing date
27 May 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
25 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

FORM 6-K

Filing date
23 May 2022
Reporting date
23 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

IAIN MACKAY - EXTERNAL APPOINTMENT

Filing date
19 May 2022
Reporting date
19 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264759

424B3

Filing date
17 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-232726

424B3

Filing date
17 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

CHANGE OF NAME TO GSK PLC

Filing date
16 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

AMENDMENT TO FORM SC 13D

Filing date
13 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
13 May 2022
Reporting date
13 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
12 May 2022
Reporting date
12 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BLOCK LISTING INTERIM REVIEW

Filing date
11 May 2022
Reporting date
11 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
09 May 2022
Reporting date
09 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-15170

25-NSE filing

Filing date
09 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-6EF File 333-264759

F-6

Filing date
06 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

RESULT OF AGM

Filing date
04 May 2022
Reporting date
04 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTORATE CHANGE

Filing date
04 May 2022
Reporting date
04 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
03 May 2022
Reporting date
03 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-15170

25-NSE filing

Filing date
02 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

1ST QUARTER RESULTS

Filing date
27 Apr 2022
Reporting date
27 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
26 Apr 2022
Reporting date
26 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DAPRODUSTAT APPLICATION ACCEPTED FOR REVIEW BY FDA

Filing date
19 Apr 2022
Reporting date
19 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .